Business Context and Reporting Period
This Form 8-K is a current report filed by Global Medical REIT Inc. (GMRE) on March 5, 2020, regarding events occurring on March 3, 2020. The filing details the Board of Directors' approval of 2020 Long-Term Incentive Plan (LTIP) awards for executive officers and employees of the external manager, as well as annual compensation for independent directors. Note: The request metadata references "Chiron Real Estate Inc.," but the filing text explicitly identifies the registrant as Global Medical REIT Inc.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive and director compensation arrangements.
- Stock Price Reference: The closing price of common stock on the NYSE on the grant date (March 3, 2020) was $14.34 per share.
- Executive Awards (Target Value):
- Jeffrey Busch (CEO): $138,000 (Performance) + $92,000 (Time-Based)
- Alfonzo Leon (CIO): $126,000 (Performance) + $84,000 (Time-Based)
- Robert Kiernan (CFO): $108,000 (Performance) + $72,000 (Time-Based)
- Jamie Barber (General Counsel): $84,000 (Performance) + $56,000 (Time-Based)
- Allen Webb (SVP): $78,000 (Performance) + $52,000 (Time-Based)
- Director Compensation (Annual):
- Independent Director Retainer: $40,000 cash + $40,000 equity.
- Committee Chair Retainers: Range from $7,000 to $15,000.
- Lead Independent Director Retainer: $15,000.
Material Changes
The filing reports the establishment of new 2020 Long-Term Performance-Based and Time-Based incentive awards. There is no prior comparable period data provided in this specific filing to quantify changes in compensation structure versus previous years, other than the initiation of the 2020 cycle.
Guidance, Outlook, and Risks
Performance Metrics: The Long-Term Performance-Based Awards are contingent on a three-year performance period ending March 2, 2023 (or earlier upon Change of Control). Payouts are determined by:
- Absolute Total Shareholder Return (TSR) (75% weight):
- 0% payout if TSR < 21%.
- 50% payout at 21% TSR.
- 100% payout at 27% TSR.
- 200% payout at 33% TSR.
- Relative TSR (25% weight): Based on performance relative to the SNL U.S. Healthcare REIT Index.
- 0% payout if below 35th percentile.
- 50% payout at 35th percentile.
- 100% payout at 55th percentile.
- 200% payout at 75th percentile.
Vesting and Risks:
- Performance awards vest 50% at the end of the performance period and 50% one year later, subject to continuous service.
- Time-based awards vest in equal one-third increments annually over three years.
- Awards are subject to forfeiture if performance thresholds are not met or if employment terminates for reasons other than Cause, Good Reason, Death, Disability, Retirement, or Change of Control.
Investor Verification Checklist
- Verify the company name discrepancy between the request metadata (Chiron Real Estate Inc.) and the filing (Global Medical REIT Inc.).
- Confirm the total dilution impact of the LTIP units granted (approx. 45,370 performance units and 30,823 time-based units) against the current share count.
- Review the specific terms of the "Change of Control" and "Good Reason" definitions in the attached Exhibits 99.1 and 99.2 to understand acceleration triggers.
- Monitor the company's TSR performance relative to the SNL U.S. Healthcare REIT Index over the next three years to assess potential payout liability.